The National Biotechnology Initiative Act of 2025 establishes a coordinated federal effort to advance biotechnology research and commercialization for national security, economic competitiveness, and scientific progress. The bill creates a new National Biotechnology Coordination Office—headed by a presidential appointee—and an Interagency Committee with representatives from 14 federal agencies to oversee initiatives across research, data management, workforce development, regulatory approval, and international cooperation. The National Science Foundation will provide approximately $132 million in funding over fiscal years 2026-2030, with the Office operating for 20 years before transitioning to a supporting role. Key deliverables include a federal biotechnology website (within 18 months), annual reports, five-year national strategies, and independent audits, while the bill also prioritizes streamlining regulatory pathways for biotech products, improving biosafety frameworks, developing a skilled workforce, and coordinating with allied nations on biotechnology standards. The initiative addresses seven major areas: centralized biological databases, private sector commercialization support, product approval efficiency, risk management, workforce training, public communication, and international regulatory alignment.
Take Action
Your position
Add a comment
to comment on this bill.
Annotate the text
Highlight any passage on the Summary or Full Text tab to attach a note. Annotations appear on the Annotations tab.